Phase II trial of vinblastine in advance
โ
Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani
๐
Article
๐
1990
๐
Springer US
๐
English
โ 231 KB
A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro